Stage IV Lung Cancer: Joanne's Patient Story

Patient Info: Joanne Sabol, Female, 60s | Stage IV

Metastatic Site: abdomen

More than 2 years after starting pembrolizumab for recurrent Stage IV lung cancer, Joanne had an 81% tumor reduction and continued to feel well while remaining on treatment.

Memorial Sloan KetteringRead more →

Stage IV ALK Lung Cancer: Leslie's Patient Story

Patient Info: Leslie, female | Stage IV

Biomarkers: ALK-positive

Metastatic Site: brain

Her brain metastases responded to targeted therapy without radiation, and she remains active and planning for the future while participating in a clinical trial.

GO2 FoundationRead more →

Lung Cancer: Felipe's Patient Story

Patient Info: Felipe, male, 60s

Felipe has moved beyond surgery and continues regular surveillance scans while rebuilding his health and life after treatment.

GO2 FoundationRead more →

Balance After Cancer - Is it Even Possible? (Part 1 of 2) — Case 1

Patient Info: Anonymized, Under 40 | Stage IV

Metastatic Site: liver; brain; bone

At age 35, the patient had lived with Stage IV lung cancer for 6 years after spread to the liver, brain and bone. The patient remained ambulatory while receiving a 10th treatment line.

Balance After Cancer - Is it Even Possible? (Part 1 of 2)

Patient Info: Anonymized, Male, 70+ | Stage III

At age 72, the patient was 5 years beyond lung surgery, breathing normally with one lung and described as in remission. A separate 2-year history of prostate cancer was asymptomatic and also described as in remission.

Stage II KRAS Non-Small Cell Lung Cancer: Camila's Patient Story

Patient Info: Camila Bermúdez García, Female, Under 40 | Stage II

Biomarkers: KRAS mutation

Camila is preparing to apply to medical school and advocates for young adults affected by lung cancer in Puerto Rico while continuing to process the effects of diagnosis and treatment.

Lung Cancer: Lisa's Patient Story

Patient Info: Lisa Bistline, Female

Biomarkers: Actionable biomarker identified on a later biopsy; specific marker not reported

Lisa’s care continued through multiple treatments, with a later biopsy changing the treatment path to biomarker-directed targeted therapy.

Stage IV Lung Cancer: Michael's Patient Story

Patient Info: Michael O’Donnell, Male | Stage IV

More than 5 years after a Stage IV diagnosis, Michael remained on immunotherapy with disease controlled to his and his doctor’s satisfaction and scans every 3 months to watch for growth.

Stage IV Lung Cancer: Mary's Patient Story

Patient Info: Mary Lynn Moser, Female | Stage IV

Metastatic Site: brain

Mary Lynn wrote this message before her death after nearly 10 years with lung cancer and more than 5 years with brain metastases, while receiving aggressive immunotherapy and chemotherapy.

Stage IV EGFR Lung Cancer: Marnie's Patient Story

Patient Info: Marnie Clark, Female | Stage IV

Biomarkers: EGFR-positive

Metastatic Site: brain

Two years after diagnosis, Marnie reported that the brain tumor was gone, her leg was almost back to normal, and her first targeted medication continued to control the lung cancer.

Lung Cancer: Xavier's Patient Story

Patient Info: Xavier Sanders, Male | Stage Metastatic/Advanced

Metastatic Site: kidneys

Xavier’s lung disease had cleared, but cancer in his kidneys remained under treatment with 2 pills daily and checkups every 3 months; he reported major improvement in his mental health after seeking help.

Lung Cancer: Nate's Patient Story

Patient Info: Nate, Male

Nate remained in lung-cancer treatment while he and his partner adjusted their plans for parenthood and focused on making memories together.

Lung Cancer: Randi's Patient Story

Patient Info: Randi Young, Female, 70+

At age 70, Randi was living with lung cancer after lobectomy and while taking targeted therapy, and she continued skiing, jogging, and solo backpacking while completing an 11-mile event.

Katie's Marathon: 25% Less Lung and 25% More Heart

Patient Info: Katie, Female, Under 40

After a lobectomy for neuroendocrine lung cancer diagnosed during pregnancy, Katie was described as a lung-cancer survivor and later completed the Paris Marathon.

Stage IV ALK Lung Cancer: Sharon's Patient Story

Patient Info: Sharon Schneider, Female, 50s | Stage IV

Biomarkers: ALK-positive

Metastatic Site: brain

After brain metastases and about 2 years of oral chemotherapy, Sharon remained in treatment, resumed jogging at least 3 days a week, and completed her first marathon at age 50.

Small Cell Lung Cancer: Nina's Patient Story

Patient Info: Nina, Female

Nina’s tumors began shrinking within weeks of starting trial immunotherapy, and she remained on the trial for 3 years without treatment side effects.

Stage IV EGFR Non-Small Cell Lung Cancer: Rachael's Patient Story

Patient Info: Rachael Malmberg, Female | Stage IV

Biomarkers: EGFR-positive; specific alteration not reported

Rachael remained highly active, working full time, leading radon-advocacy organizations, and raising her 6-year-old daughter while living with Stage IV EGFR-positive NSCLC.

Stage IV Lung Cancer: Carla's Patient Story

Patient Info: Carla, Female | Stage IV

Metastatic Site: brain

After repeated resistance and a serious episode involving a brain lesion and extensive fluid around the lung, Carla recovered and was stable without new symptoms on her eighth line of treatment.

10 Tips for Lung Cancer Caregiving

Patient Info: Anonymized, Female | Stage IV

Metastatic Site: brain

She died about 5 years after her 2015 diagnosis, after her family cared for her through progressive illness and increasing daily needs.

Many Hats of Caregiving (Part 3 of 3)

Patient Info: Anonymized, Male | Stage III

Carla’s father was described as having survived Stage III lung cancer and being in remission; he was also in remission from a separate early-stage prostate cancer.

Stage I Non-Small Cell Lung Cancer: Robert's Survivor Story

Patient Info: Robert Tumanic, Male | Stage I

After SBRT, follow-up scans showed the treated tumors resolved and no additional tumors requiring treatment; as of May 2019, the treated sites were stable and no further lung-cancer therapy was required.

Lung Cancer: Jeff's Patient Story

Patient Info: Jeff, Under 40

Two and a half years after diagnosis at age 34, targeted therapy had restored much of Jeff’s mobility and reduced the physical effects of lung cancer.

Stage III KRAS Lung Cancer: Bill's Survivor Story

Patient Info: Bill Morris, Male | Stage III

Biomarkers: KRAS

After multimodal treatment, Bill had remained actively cancer-free for more than 3 years and used his experience to support other patients.

We're Back! Q&A With Breathe Deep TOGETHER Team Captains — Case 2

Patient Info: Anonymized | Stage I

This patient reported being 13 years cancer-free after Stage I lung cancer, while still experiencing recurrence anxiety around follow-up visits.